Asset Intelligence / Hyperliquid Context
Eli Lilly and Company / LLY
Archive-backed market intelligence for LLY: every HIPERWIRE mover article tied to this asset, plus a client-refreshed live market panel.
LLY tracks the value of 1 share of common stock in Eli Lilly and Company. Eli Lilly develops and manufactures pharmaceuticals, including treatments for diabetes, oncology, immunology, and other therapeutic areas.
Live Structure
Market Status
Loading current market structure...
- Builderxyz
- Categorystock
- Tracked Marketxyz:LLY
- Latest Tweet—
No other live markets from this builder in the current screener.
No same-category alternatives are live in the current screener snapshot.
Archive Summary
Latest Archived Thesis
How to Trade Eli Lilly and Company (LLY) on Hyperliquid
Eli Lilly is the largest pharmaceutical company in the world by revenue, driven by blockbuster GLP-1 drugs Mounjaro and Zepbound that generated $36.5 billion combined in 2025. LLY is now available as a HIP-3 perpetual futures contract on Hyperliquid, giving traders leveraged exposure to one of the most consequential names in biopharma without touching traditional equity markets.
Background reading selected from this asset's symbol, builder context, and archived catalyst coverage.
HIP-3 Explained: Anyone Can Launch Hyperliquid Perps
HIP-3 lets anyone deploy a perpetual futures market on Hyperliquid — no approval needed. How builders launch markets, post stake, and earn fees.
Funding Rates Explained: A Trader's Guide (2026)
Funding rates decide if you pay or earn holding a perp position. How Hyperliquid's hourly funding works, reading rate signals, and cash-and-carry arbitrage.